Association of Atrial Fibrillation With Cognitive Decline and Dementia Over 20 Years: The ARIC-NCS (Atherosclerosis Risk in Communities Neurocognitive Study)

Lin Y Chen, Faye L Norby, Rebecca F Gottesman, Thomas H Mosley, Elsayed Z Soliman, Sunil K Agarwal, Laura R Loehr, Aaron R Folsom, Josef Coresh, Alvaro Alonso, Lin Y Chen, Faye L Norby, Rebecca F Gottesman, Thomas H Mosley, Elsayed Z Soliman, Sunil K Agarwal, Laura R Loehr, Aaron R Folsom, Josef Coresh, Alvaro Alonso

Abstract

Background: Previous studies have reported that atrial fibrillation (AF) is associated with cognitive decline and dementia. These studies, however, had limited follow-up, were based mostly on white and highly selected populations, and did not account for attrition. We evaluated the association of incident AF with 20-year change in cognitive performance (accounting for attrition) and incident dementia in the ARIC (Atherosclerosis Risk in Communities) Study.

Methods and results: We analyzed data from 12 515 participants (mean age, 56.9 [SD, 5.7] years in 1990-1992; 56% women and 24% black) from 1990 to 1992 through 2011 to 2013. Incident AF was ascertained from study ECGs and hospital discharge codes. Cognitive tests were performed in 1990 to 1992, 1996 to 1998, and 2011 to 2013. Incident dementia was clinician adjudicated. We used generalized estimating equations and Cox proportional hazards models to assess the association of time-dependent AF with change in Z scores of cognitive tests and incident dementia, respectively. During 20 years, 2106 participants developed AF and 1157 participants developed dementia. After accounting for cardiovascular risk factors, including ischemic stroke, the average decline over 20 years in global cognitive Z score was 0.115 (95% confidence interval, 0.014-0.215) greater in participants with AF than in those without AF. Further adjustment for attrition by multiple imputation by chained equations strengthened the association. In addition, incident AF was associated with an increased risk of dementia (hazard ratio, 1.23; 95% confidence interval, 1.04-1.45), after adjusting for cardiovascular risk factors, including ischemic stroke.

Conclusions: AF is associated with greater cognitive decline and increased risk of dementia, independent of ischemic stroke. Because cognitive decline is a precursor to dementia, our findings prompt further investigation to identify specific treatments for AF that will delay the trajectory of cognitive decline and, thus, prevent dementia in patients with AF.

Keywords: atrial fibrillation; cognition; cohort study; dementia; epidemiology.

© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.

Figures

Figure 1
Figure 1
Flow diagram of participants in the study, ARIC‐NCS (Atherosclerosis Risk in Communities Neurocognitive Study). AF indicates atrial fibrillation.

References

    1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–2375.
    1. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TSM. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–125.
    1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–988. PMID:1866765.
    1. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920–2925.
    1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–952.
    1. Chen LY, Sotoodehnia N, Bůžková P, Lopez FL, Yee LM, Heckbert SR, Prineas R, Soliman EZ, Adabag AS, Konety S, Folsom AR, Siscovick D, Alonso A. Atrial fibrillation and the risk of sudden cardiac death: the Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS). JAMA Intern Med. 2013;173:29–35.
    1. Chen LY, Lopez FL, Gottesman RF, Huxley RR, Agarwal SK, Loehr L, Mosley T, Alonso A. Atrial fibrillation and cognitive decline‐the role of subclinical cerebral infarcts: the Atherosclerosis Risk in Communities study. Stroke. 2014;45:2568–2574.
    1. Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day JD. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart Rhythm. 2010;7:433–437.
    1. Dublin S, Anderson ML, Haneuse SJ, Heckbert SR, Crane PK, Breitner JC, McCormick W, Bowen JD, Teri L, McCurry SM, Larson EB. Atrial fibrillation and risk of dementia: a prospective cohort study. J Am Geriatr Soc. 2011;59:1369–1375.
    1. Elias MF, Sullivan LM, Elias PK, Vasan RS, D'Agostino RB Sr, Seshadri S, Au R, Wolf PA, Benjamin EJ. Atrial fibrillation is associated with lower cognitive performance in the Framingham offspring men. J Stroke Cerebrovasc Dis. 2006;15:214–222.
    1. Marengoni A, Qiu CX, Winblad B, Fratiglioni L. Atrial fibrillation, stroke and dementia in the very old: a population‐based study. Neurobiol Aging. 2011;32:1336–1337.
    1. Peters R, Poulter R, Beckett N, Forette F, Fagard R, Potter J, Swift C, Anderson C, Fletcher A, Bulpitt CJ. Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial. J Hypertens. 2009;27:2055–2062.
    1. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population‐based study: the Rotterdam Study. Stroke. 1997;28:316–321.
    1. Cacciatore F, Abete P, Ferrara N, Calabrese C, Napoli C, Maggi S, Varricchio M, Rengo F; Osservatorio Geriatrico Campano Study Group. Congestive heart failure and cognitive impairment in an older population. J Am Geriatr Soc. 1998;46:1343–1348.
    1. Tilvis RS, Kahonen‐Vare MH, Jolkkonen J, Valvanne J, Pitkala KH, Strandberg TE. Predictors of cognitive decline and mortality of aged people over a 10‐year period. J Gerontol A Biol Sci Med Sci. 2004;59:268–274.
    1. Forti P, Maioli F, Pisacane N, Rietti E, Montesi F, Ravaglia G. Atrial fibrillation and risk of dementia in non‐demented elderly subjects with and without mild cognitive impairment (MCI). Arch Gerontol Geriatr. 2007;44:155–165.
    1. Marzona I, O'Donnell M, Teo K, Gao P, Anderson C, Bosch J, Yusuf S. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ. 2012;184:E329–E336.
    1. de Bruijn RF, Heeringa J, Wolters FJ, Franco OH, Stricker BH, Hofman A, Koudstaal PJ, Ikram MA. Association between atrial fibrillation and dementia in the general population. JAMA Neurol. 2015;72:1288–1294.
    1. Collaborative Studies Coordinating Center . Atherosclerosis Risk in Communities Study. University of North Carolina at Chapel Hill. . Accessed January 8, 2018.
    1. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol. 1989;129:687–702.
    1. Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ, Folsom AR. Incidence of atrial fibrillation in whites and African‐Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009;158:111–117.
    1. Soliman EZ, Prineas RJ, Case LD, Zhang ZM, Goff DC Jr. Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2009;40:1204–1211.
    1. Knopman DS, Ryberg S. A verbal memory test with high predictive accuracy for dementia of the Alzheimer type. Arch Neurol. 1989;46:141–145.
    1. Wechsler D. Wechsler Adult Intelligence Scale–Revised. New York, NY: Psychological Corp; 1981.
    1. Lezak MD. Neuropsychological Assessment. 3rd ed New York, NY: Oxford University Press; 1995.
    1. Schneider ALC, Sharrett AR, Gottesman RF, Coresh J, Coker L, Wruck L, Selnes OA, Deal J, Knopman D, Mosley TH. Normative data for 8 neuropsychological tests in older blacks and whites from the Atherosclerosis Risk in Communities (ARIC) study. Alzheimer Dis Assoc Disord. 2015;29:32–44.
    1. Rawlings AM, Sharrett AR, Schneider AL, Coresh J, Albert M, Couper D, Griswold M, Gottesman RF, Wagenknecht LE, Windham BG, Selvin E. Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med. 2014;161:785–793.
    1. Gottesman RF, Schneider ALC, Albert M, Alonso A, Bandeen‐Roche K, Coker L, Coresh J, Knopman D, Power MC, Rawlings A, Sharrett AR, Wruck LM, Mosley TH. Midlife hypertension and 20‐year cognitive change: the Atherosclerosis Risk in Communities (ARIC) Neurocognitive Study. JAMA Neurol. 2014;71:1218–1227.
    1. Elias PK, Elias MF, DAgostino RB, Cupples LA, Wilson PW, Silbershatz H, Wolf PA. NIDDM and blood pressure as risk factors for poor cognitive performance: the Framingham Study. Diabetes Care. 1997;20:1388–1395.
    1. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263–269.
    1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:270–279.
    1. Knopman DS, Gottesman RF, Sharrett AR, Wruck LM, Windham BG, Coker L, Schneider ALC, Hengrui S, Alonso A, Coresh J, Albert MS, Mosley TH Jr. Mild cognitive impairment and dementia prevalence: the Atherosclerosis Risk in Communities Neurocognitive Study. Alzheimers Dement (Amst). 2016;2:1–11. DOI: .
    1. Eriksson H, Caidahl K, Larsson B, Ohlson LO, Welin L, Wilhelmsen L, Svardsudd K. Cardiac and pulmonary causes of dyspnea—validation of a scoring test for clinical‐epidemiologic use—the Study of Men Born in 1913. Eur Heart J. 1987;8:1007–1014.
    1. Weinfeld FD, Adelman SM, Baum HM, Robins M, Walker AE, Weiss W. The national survey of stroke. Stroke. 1981;12:I1–I91.
    1. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–399.
    1. Rawlings AM, Sang Y, Sharrett AR, Coresh J, Griswold M, Kucharska‐Newton AM, Palta P, Wruck LM, Gross AL, Deal JA, Power MC, Bandeen‐Roche KJ. Multiple imputation of cognitive performance as a repeatedly measured outcome. Eur J Epidemiol. 2017;32:55–66.
    1. Thacker EL, McKnight B, Psaty BM, Longstreth WT Jr, Sitlani CM, Dublin S, Arnold AM, Fitzpatrick AL, Gottesman RF, Heckbert SR. Atrial fibrillation and cognitive decline: a longitudinal cohort study. Neurology. 2013;81:119–125.
    1. Rastas S, Verkkoniemi A, Polvikoski T, Juva K, Niinisto L, Mattila K, Lansimies E, Pirttila T, Sulkava R. Atrial fibrillation, stroke, and cognition: a longitudinal population‐based study of people aged 85 and older. Stroke. 2007;38:1454–1460.
    1. Knopman DS, Mosley TH, Catellier DJ, Coker LH. Fourteen‐year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement. 2009;5:207–214.
    1. Reed BR, Eberling JL, Mungas D, Weiner M, Kramer JH, Jagust WJ. Effects of white matter lesions and lacunes on cortical function. Arch Neurol. 2004;61:1545–1550.
    1. Roberts RO, Geda YE, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, Vella A, Rocca WA, Petersen RC. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol. 2008;65:1066–1073.
    1. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L. The role of APOE epsilon 4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA. 1999;282:40–46.
    1. Wilson RS, Schneider JA, Barnes LL, Beckett LA, Aggarwal NT, Cochran EJ, Berry‐Kravis E, Bach J, Fox JH, Evans DA, Bennett DA. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6‐year period. Arch Neurol. 2002;59:1154–1160.
    1. Mayeux R, Small SA, Tang MX, Tycko B, Stern Y. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein‐E. Neurobiol Aging. 2001;22:683–689.
    1. Lavy S, Stern S, Melamed E, Cooper G, Keren A, Levy P. Effect of chronic atrial‐fibrillation on regional cerebral blood‐flow. Stroke. 1980;11:35–38. PMID:7355427.
    1. de Leeuw FE, de Groot JC, Oudkerk M, Kors JA, Hofman A, van Gijn J, Breteler MM. Atrial fibrillation and the risk of cerebral white matter lesions. Neurology. 2000;54:1795–1801.
    1. Piers RJ, Nishtala A, Preis SR, DeCarli C, Wolf PA, Benjamin EJ, Au R. Association between atrial fibrillation and volumetric magnetic resonance imaging brain measures: Framingham Offspring Study. Heart Rhythm. 2016;13:2020–2024.
    1. Stefansdottir H, Arnar DO, Aspelund T, Sigurdsson S, Jonsdottir MK, Hjaltason H, Launer LJ, Gudnason V. Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts. Stroke. 2013;44:1020–1025.
    1. Anderson JL, Maycock CAA, Lappe DL, Crandall BG, Horne BD, Bair TL, Morris SR, Li QY, Muhlestein JB; Intermountain Heart Collaborative Study Group . Frequency of elevation of C‐reactive protein in atrial fibrillation. Am J Cardiol. 2004;94:1255–1259.
    1. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96:2455–2461.
    1. Chen LY, Agarwal SK, Norby FL, Gottesman RF, Loehr LR, Soliman EZ, Mosley TH, Folsom AR, Coresh J, Alonso A. Persistent but not paroxysmal atrial fibrillation is independently associated with lower cognitive function: ARIC Study. J Am Coll Cardiol. 2016;67:1379–1380.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera